Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Weihai Weigao to Distribute TriReme’s Cardiology Devices in China

publication date: Mar 26, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Weihai Weigao Medical Devices will distribute TriReme Medical’s portfolio of innovative catheters and stents in China. TriReme is a US-Singapore medical device maker. Weigao will sell TriReme’s products directly to hospitals and through its network of distributors. TriReme’s avowed strategy is to sell its minimally invasive interventional cardiology products in the US and Asia. The company previous signed up a Japan distribution partner. More details....

Stock Symbol: (HK: 1066)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...